4//SEC Filing
Hasara Garrison J. 4
Accession 0001181431-12-013879
CIK 0001310094other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:38 PM ET
Size
5.5 KB
Accession
0001181431-12-013879
Insider Transaction Report
Form 4
Hasara Garrison J.
Acting Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-02-29+100,000→ 100,000 totalExercise: $0.44From: 2012-02-29Exp: 2022-03-01→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Exercise price is 100% of fair market value on date of grant.
- [F2]The options vested immediately on the date of grant.
- [F3]The options terminate 10 years from the grant date, or 90 days after the employee ceases to be an employee for any reason, other than death, disability or retirement.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeother
Related Parties
1- filerCIK 0001510349
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:38 PM ET
- Size
- 5.5 KB